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Mutations in the genes encoding laminin 5 (LAMA3, 
LAMB3, and LAMC2) have been delineated in the 
autosomal recessive blistering skin disorder, junc-
tional epidermolysis bullosa, particularly in the lethal 
(Herlitz) variant. In this study, we searched for mu-
tations in these genes in two patients with nonlethal 
fortDS of junctional epidermolysis bullosa using poly-
merase chain reaction amplification of genom.ic 
DNA, followed by heteroduplex analysis and direct 
automated nucleotide sequencing. Both patients 
I n the lethal (Berlitz) forms of junctional epidermol ys is bullosa UEB), several difFerent premature termination codo n mutations have been fo und o n both alleles of e ithe r the LAMA3 , LAMB3, or LAMC2 genes that encode lallli-niJl 5 (Aberdam ef Il l, 1994; Kivirikko el 111, 1995; M cGrath 
e( 111, 1995b; Pulkkinen CIIlI, 1994b). In the no nlethal forms of JEB, 
fewer mutations ha ve been described. T hese consis t of premature 
termination codons in both all eles of the BPAG2 gene in a patient 
with the generalized atrophic benign epidermolys is bullosa variant 
of non lethal JEB (McGrath e/ Ill, 1995a), ,1 homozygous in-fram e 
exon skipping mutation in the LAMC2 gene in a subtype of 
nonle thal JEB (Pulkkinen et Ill, 1994a) and compound heterozygos-
ity for a nonsense and missense mutatio n in the LAMB3 gene in 
another pedigree with generali zed atrophic benign e pidermolysis 
bullosa (McG rath et Il l , 1995c). 
In this study, we report two cases of nonlethal J EB with a 
combination of a nonsense and a missense mutation in the LAMB3 
gene, suggestin g that this particul ar combination of mutations m ay 
be important in the pathogenesis of this form of inherited b listering 
skin disease . 
MATETUALS AND METH O DS 
Clinicopathological Features Patiellt l is a I-year-old fema le infant of 
unre lated , cljnicall y norma l parents o f North Am erican Caucasian an ces try. 
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were found to be compound heterozygotes for the 
same nonsense mutation on one LAMB3 allele, and 
different missense mutations on the other LAMB3 
allele. The combination of a nonsense and a missense 
mutation in the LAMB3 gene appears to be itnportant 
in determining the milder clinical phenotype in some 
cases of the nonlethal fOrIns of junctional epidermol-
ysis bullosa involving abnormalities in laminin 5. Key 
I/IoJlds: lami"i" 5Ia1tc/'oJli1tg filam e"ts. ] r,,,,est De,..matol 
106: 1157-1159, 1996 
T here was 11 0 histo ry of a blistering d iso rde r in the fa mil y. At birth, a few 
sc,lt(ered blis te rs were present 0 11 th e trunk and limbs. Over subsequent 
\vccks and 1110 I1 t h s, tni ld. traulna-Olssoci.,ltcd bli stering and crusting occurred 
on the back. groin arca , e lbows. hands. and feet. T here has been no 
sig niti c:1 n t 111U CO US 111 clnbr;lIlC il1v o l vClllCllt to date. ho \vcvt.!r . Elec tro tl 
microscopic examination of skin showed a lamina lucida plane of cleavage 
consistent with a dia gnosis of) Ell. 
Pa tient 2 is a 75- yea r-o ld Northern Euro pean Caucasian wO lnan \vitll 
gene rali zed trauma-induced bli stering since birth, predominantly affecting 
the sacral area. Other clinical features include scarring alopecia. esoph agea l 
stri cture forl1lation, and dystro phic tee th an d nails. There is no re levant 
f.1 mil y history. and the unrelated parents, now deceased, we re clinically 
n ornlO' l. l nlll1\.lnofluorcscenc~ 111.1 CrOscopy of th e cutancous bascill ent Inenl-
brane zone re veal ed reduced staining with an antibody (GB3) ro laminin 5 
(Kennedy cl ai, 1985; Schofie ld {'( ai, 1990). Elec tron microscopy showed 
bUster fOl1nation within the lamin:l lucida. but no gross chan ges in hemjdcs-
m osom e and ancho ring ftl am cllt morphology (Tidman and Eady, 1986) . 
Overall . these findings arc consisten t w ith a nonIethal fo rm ofJEB. 
Mutation Analysis DNA was iso lated from peripheral blood lympho-
cy tes from patient 1, the parellts of patiellt I. and patient 2 by standard 
methods (Sam brook ct ai, 1989) and used as a template for amplification of 
individua l eXOm of the LAMA3, LAMB3, and LAMC2 genes. O ligonucle-
otide prim ers wcre synthesized o n the basis of intronic sequences, as 
described prev ious ly (Pulkkinen et ai, 1995). SpecificaJly, to ampli fy exons 
7, 10, and 14 o f LAtlilB3 (see Reslllts) the fo llowing prime rs were used: 
"xon 7. scnse pomer: S' AGGTI'TCTTCTGAACTCGGG 3' : 
cxon 7, antisense primer: 5' GCAGGGCAAGTATCAAATCC 3'. 
exon 10, sense primer: 5 ' GAGTTGTTACAGATGCCAGT 3': 
exon 10, anti sense primer: S' TCTCCCCACAAATCCTGACTC 3'. 
exonl4. sense primer: 5' GCTGCGACTTCTGTTATTCT 3' : 
eXon 14. antisense primer: 5 ' AAATGTAAGGAAGGACCAGC 3' . 
The polymerasc chain reaction (PCR) amplifi ca tion conditions were the 
same as desc ribed prev io usly. Aliquots of 5 ILL of the PC R products were 
analyzed by 2'% agarose gel e lectrophoresis . To detect sequence vari'lIlts, 
the PC R products were eithe r subjected directly to automated nucleotide 
sequencing (AB I). o r 3-8 ILL of the sample was screened by heteroduplcx 
analysis using; con fonn arion-sensitivc gel electrophoresis (Gang uly c( al. 
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Figure 1. Identification of a nonsense mutation (R635X) in one 
IAMBJ allele in both affected individuals. A) Automated nucleo tide 
sequencing of the PC R products encol11passing cxon 14 in both patien t 1 
and patient 2 re vea ls a he terozygous C-to-T trans itio n at position 1903 that 
con verts a n arginine residue (.eGA) to :l prClllaturc tcrrllinntio Jl codon 
(IGA). T his mutatio n is des igna ted R635X. B) T he R635X mutation 
creates a new restri ction site fo r the endonuclease ~~II I. T he contro l PCR 
product shows a single , undigested band, 578 bp in size . In contrast, the 
samples from both pacient 1 and patient 2 ha ve add itional ballds, 428 and 
150 bp in size. Digestion of the ampli~icd DNA of the fat her of pa tient 'I al so 
shows the addi tional bands, indicating that he is a heterozygous ca rri er of 
the mutation R.635X. The PCR. product of the mother of patient 1 is not 
d igested by BgllI , as seen ill the control sample. 
1993), fo llowed by direc t automated sequencing of PC R products di spJay-
ing bands of altered mo bili ty . 
Verification of tlte Mutations T he mu tations detected in the pCR 
ptoducts (sec R/!.",lts) were verifi ed in genomic D N A. To ve ri fy the 
lIIu tatio ns in exon 7 and exon 10 in LAMBJ, o ligonucleotide probes 
covering the site of the mutatio ns were designed for ,dl elc-specific o ligo-
(A) 
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nucleotide (ASO) h )'bridization of the PC R products spanning the Illllta-
tiOIlS . A sta lldard ASO protocol WilS used (Dietz el nl, 1992). The probes 
were as fo llows: 
exon 7: wild type. 5 ' AAAAATTCAAriGTCAGTGTGG 3'; 
exon 7: mutated allele. 5' AAAAAATTCAA&GTCAGTGTGG 3 ' . 
exoll 10: wild type, 5' CGGGACCAC~CCGAAGGCAA 3'; 
exon 10: mu tatcd allele, 5' CGGGACCAC£;CCGAAGGCA 3'. 
Fifty ethni call y matched, unre lated hea lth y contro l subjects werc al 0 
assessed fo r the presence or absence of this nlu tation. 
T he exon 14 mutatio ll in LA MB] crea ted a new rcstJictioll site for dle 
endo lluclease ~~/ II. The PC R. prod ucts spanning thi s eXOll were digested 
w ith thi s enzyme according to the m anufacturer 's instructions (New 
England Biolabs, Inc., Beverly, M A) . 
RES ULTS 
Identification of the Same Nonsense Mutation in one 
LAMB3 Allele in Both Affected Individuals Direct nucleo-
tide sequencing of the PC R produ cts spanning exon 14 (Fig lA) in 
both pati ent 1 and pati ent 2 re vea led a C-to-T transition at 
nucl eotide position 1903 (GenBank accession number L25541) that 
converts an arginine codon (eGA) to a stop codon (IGA) . Tlu 
muta tion, designated R 635X, creates a new restriction site for the 
e ndonuclease BglIl. Digestion of the PC R products with this 
enzyme (Fig 1B) showed an undigested band of578 bp in amplified 
control DNA. T he PC R products o f both patients displayed 
digestion products 578, 428 , and 150 bp in size, however, indicat-
ing heterozygosity for the presence of thjs mutation. In addition , 
similar bands were seen in the digested ampEfi ed DNA sample from 
the father of patient 1, indicating that he is a heterozygous carrier 
of this mutation . The m aternal sa mple was not cl eaved by BglII. 
simil ar to the control sample enzyme digestion. 
Identification of Different Missense Mutations in the Other 
LAMB3 Allele in Both Affected Individuals In patient 1, 
heteroduplex analysis of the PCR product spamung ex on 7 of 
LAMB3 (Fig 2A) revea led heterodupl ex formation in addition to a 
homoduplex band . T lus bandshift was also present in the maternal 
sa mpl e, but no t in the PC R product from the f.1 ther, a coutrol 
indi vidu al, o r patient 2. Direct nucl eotide sequencing (Fig 2B) 
revea led a G-to-A transition at nucleotide position 628 that con-
verts a glu tamic acid residue (G.AG) to a lysine residue (.!lAG). Thi 
mutation , designa ted E2 10K, was verified by ASO (Fig 2G· 
Assessment of 50 DNA samples from unrelated control individual 
by ASO fai led to demon strate the presence of tlus nussense 
mutation. 
In patient 2, direct nucleotide sequencing of the PCR product 
spanning exon 10 of LA MB3 (Fig 3B) revealed an A-to-C trans-
versio n at nucleotide position 1048 that converts a threonine 
res idll e (ACC) to a proline residue (CCC). T his mutation, desig-
nated T350 P, was verified by ASO. Assessment of 50 DNA sample 
(8) Figure 2. Identification of the missense mutation E210K in one IAMBJ allele in 
patient 1. A) I-l eteroduplex analysis of the PCR 
ptoducts spanning exon 7 shows hete roduplex 
fo rma tion in addi tio n to a hom oduplex band in 
the amplified DNA liom patient 1 and the 
m o ther of patient 1 . In contrast, o nl y the ho mo-
dup lex band is detected in the samples from the 
fat her of patien t 1 and the contro l indi vidual. B) 
Nucleotide sequencing of the PCR product of 
patient ! revea ls a heterozygous G-to-A transi-
tion at position 628 thac conve rts a spli t glu tamic 
"cid codon (G.AG) to a lys ine residue (&AG). 
T he muta tion is designated E210K. C) Verifica-
tion of the missense mutation by ASO shows 
sig n"l s for the wild type ( //It) and the mut'lI1t 
(IIlIlt) scquences in the pCR product of p" ticn t J 
and thc mother of paticnt!, bu t onl y the w ild 
type signal is present in the father of patient 1 
and the control sample. 
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Figure 3. Identification of the missense mutation T350P in one 
IAMB) allele in patient 2. A) Automated nucleotide sequencing of the 
PCR product encompassing exon 10 in patient 2 reveals a heterozygous 
A- to-C transversion at nucleotide position 1048 that converts a threonine 
residue (.t1CC) to a proline residue (!:;CC) . T he mutation is designated 
T3 50P. B) Verification of the missense mutation by ASO shows signals for 
the w ild type and mutant sequcuces in the amplified DNA of patient 2. but 
only the w ild type signal in tbe control sample. 
from unrelated control indiv iduals by ASO failed to demonstrate 
the presence of this missense mutation. 
DlSC USSION 
Both nonlethal JEB patients in this study are compound hetemzy-
gotes for a nonsense mutation on one LAMB3 allele and a missense 
mutation on the other LANIB3 aUe le. T he no nsense mutatio n 
consists of a prematlU'e termination codo n ill exon 14, designated 
R63SX. This mutation is expected to result in an unstable mRNA 
transcript and , as a consequence, an absence of protein from this 
allele (Urlaub el ai , 1989; Cheng et ai, 1990). T his hypothesis is 
supported by a previous demonstration of a complete lack of 
LAMB3 mRNA in a patient withJEB homozygous for th e R63SX 
mutation (Pulkkinen cl (II, 1994b). Interestingly, this nonsense muta-
tion has also been observed in several other unrelated patients with 
lethal (Herlitz) and nonlethal fOl1llS of JEB £iom diverse ethnic 
backgrounds (Kivirikko el ai, 1996) and would therefore appear to 
constitute a mutational hotspot in the LAA1B3 gene. 
Both the nonsense mutation and the two missense mutations 
delineated in this study conld not be demonstrated in 100 unrelated 
chromosomes within ethnically matched control populations, argu-
ing against these amino acid substi tutions representing nOllpatho-
genetic polymorphisl11s. T he mutation E210K has been previously 
reported in a different family with nonlethal J ED (McGrath et ai , 
1995c), but has not been detected ill mutatio nal screening of more 
than 30 o the r patients with different forms of JEB (McGrath ci ai, 
1995c; McGrath JA ct "I, unpublished data), arguing against E21 OK 
representing a common pathogenetic mutatio n in Ilon.lethal JEB. 
The conversion of glu taillic acid to lys ine ca uses a marked change 
in polarity alJd occurs in a region of tbe laminin 5 molecule, domain 
VI, that is potentia lly important in protein-pro tein interactions 
involving laminin 5 within the cutaneous basement membrane 
zone . The mutation T3S0P occurs at a threonine residue within 
domain IlI/V of the sho rt arm of the f33 chain. It is possible that the 
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introduction of a proli.ne res idue in to this part of the mo lecule 
results in a conforma tion al change of the f33 chain short arm, 
disrup ting the normal fun ction of the protein . 
Although mutations in oth er genes, incl uding LAMe2 and 
BPAG2, have b een reported as the m olecular basis for som e cases 
of no nlethal JEB, this study suggests that mutations in the LAMB3 
gene may also be relevan t to the pathogenesis of this heterogeneous 
group of inherited blistering skin diseases. Furthermore, the com-
bination of a n o nsense and a missense mu tation ill this gene appears 
to influence the JEB phenotype by resulting in a non lethal form of 
the disease, whereas nonsense mutations on both LAMB3 aUeles 
unequivocally result in the le thal (H erli tz) varian t of JEB. 
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